Pharming Group N.V. (PHAR) Gross margin 2019–2025
Pharming Group N.V. (PHAR) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.9%FY2025 · since FY2019: 87.4% → 87.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.9% | -0.2 pp |
| FY2024 | 88.1% | -1.6 pp |
| FY2023 | 89.7% | -1.7 pp |
| FY2022 | 91.5% | +2.1 pp |
| FY2021 | 89.4% | +0.5 pp |
| FY2020 | 88.9% | +1.5 pp |
| FY2019 | 87.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Net marginPHAR Gross profitPHAR Operating incomePHAR Operating marginPHAR Operating cash flowPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →